DSGN (STOCKS)
Design Therapeutics, Inc. Common Stock
$12.350000
+0.190000 (+1.56%)
Prev close: $12.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Pratik Shah
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $761.65M
- Employees
- 55
- P/E (TTM)
- -10.13
- P/B (TTM)
- 3.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $79.47M |
| Research and Development | $59.13M |
| Other Operating Expenses | $20.34M |
| Operating Income/Loss | -$79.47M |
| Income/Loss From Continuing Operations After Tax | -$69.79M |
| Income/Loss From Continuing Operations Before Tax | -$69.79M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$69.79M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$69.79M |
| Net Income/Loss Available To Common Stockholders, Basic | -$69.79M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.22 |
| Diluted Earnings Per Share | -$1.22 |
| Basic Average Shares | 57,330,192 |
| Diluted Average Shares | 57,330,192 |
| Assets | $226.20M |
| Current Assets | $223.78M |
| Cash | $219.80M |
| Prepaid Expenses | $2.26M |
| Other Current Assets | $1.72M |
| Noncurrent Assets | $2.42M |
| Fixed Assets | $981.00K |
| Other Non-current Assets | $1.44M |
| Liabilities | $13.70M |
| Current Liabilities | $13.06M |
| Accounts Payable | $2.31M |
| Wages | $4.63M |
| Other Current Liabilities | $6.11M |
| Noncurrent Liabilities | $645.00K |
| Equity | $212.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $212.50M |
| Liabilities And Equity | $226.20M |
| Net Cash Flow From Operating Activities | -$54.36M |
| Net Cash Flow From Operating Activities, Continuing | -$54.36M |
| Net Cash Flow From Investing Activities | $22.91M |
| Net Cash Flow From Investing Activities, Continuing | $22.91M |
| Net Cash Flow From Financing Activities | $25.74M |
| Net Cash Flow From Financing Activities, Continuing | $25.74M |
| Net Cash Flow | -$5.71M |
| Net Cash Flow, Continuing | -$5.71M |
| Comprehensive Income/Loss | -$69.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$69.86M |
| Other Comprehensive Income/Loss | -$72.00K |